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Summary
It has previously been demonstrated that cell shape can
influence commitment of human bone marrow-derived
mesenchymal stem cells (hBMCs) to adipogenic, osteogenic,
chondrogenic, and other lineages. Human periosteum-derived
cells (hPDCs) exhibit multipotency similar to hBMCs, but
hPDCs may offer enhanced potential for osteogenesis and
chondrogenesis given their apparent endogenous role in bone
and cartilage repair in vivo. Here, we examined whether
hPDC differentiation is regulated by adhesive and mechanical
cues comparable to that reported for hBMC differentiation.
When cultured in the appropriate induction media, hPDCs at
high cell seeding density demonstrated enhanced levels of
adipogenic or chondrogenic markers as compared with
hPDCs at low cell seeding density. Cell seeding density
correlated inversely with projected area of cell spreading, and
directly limiting cell spreading with micropatterned
substrates promoted adipogenesis or chondrogenesis while
substrates promoting cell spreading supported osteogenesis.
Interestingly, cell seeding density influenced differentiation
through both changes in cell shape and non-shape-mediated
effects: density-dependent adipogenesis and chondrogenesis
were regulated primarily by cell shape whereas non-shape
effects strongly influenced osteogenic potential. Inhibition of
cytoskeletal contractility by adding the Rho kinase inhibitor
Y27632 further enhanced adipogenic differentiation and
discouraged osteogenic differentiation of hPDCs. Together,
our results suggest that multipotent lineage decisions of
hPDCs are impacted by cell adhesive and mechanical cues,
though to different extents than hBMCs. Thus, future studies
of hPDCs and other primary stem cell populations with
clinical potential should consider varying biophysical metrics
for more thorough optimization of stem cell differentiation.
 2012. Published by The Company of Biologists Ltd. This is
an Open Access article distributed under the terms of the
Creative Commons Attribution Non-Commercial Share Alike
License (http://creativecommons.org/licenses/by-nc-sa/3.0).
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Introduction
Mesenchymal Stem/Stromal Cells (MSCs) are cell populations
found in the stroma of mesenchymal tissues such as bone, bone
marrow, cartilage, ligaments, and adipose tissue. Because these
cell populations can be readily isolated from patients for
expansion and differentiation in vitro into at least three
different lineages (Augello and De Bari, 2010; Dominici et al.,
2006; Pittenger et al., 1999), MSCs are of great interest for
clinical therapies. Indeed, protocols for injections of autologous
MSCs are already in clinical trials not only for various
musculoskeletal tissue replacement therapies including bone,
cartilage, and intervertebral discs, but also to treat organ failure
(cardiac, lung, liver, pancreas among others) and autoimmune
diseases (for reviews, see Go´mez-Barrena et al., 2011; Trounson
et al., 2011; Tyndall and Gratwohl, 2009). Moreover, MSCs are
being developed as a critical cell source in tissue engineering,
which involves the ex vivo creation of biological implants
intended eventually to replace tissues or functional organs
(Marcacci et al., 2007). However, the molecular mechanisms
regulating MSC differentiation into the desired terminal lineages
are still incompletely understood, impeding efforts to generate
useful clinical products from primary cells obtained from
patients.
To study MSC differentiation, an array of in vitro assays has
been developed. To drive osteogenic differentiation, MSCs are
cultured in a serum-containing medium supplemented with
dexamethasone, ascorbic acid, and beta-glycerophosphate
(Jaiswal et al., 1997; Pittenger et al., 1999). Adipogenesis is
induced by insulin, isobutyl-methylxanthine, dexamethasone, and
indomethacin (Sekiya et al., 2004), and chondrogenesis is
induced in serum-free medium supplemented with TGFb
(Johnstone et al., 1998). Utilizing these media, the
differentiation capacities of MSCs derived from different
tissues and species have been compared. As virtually all of
these can undergo in vitro multilineage differentiation,
differences between MSCs have been reported mostly in terms
of differentiation efficiency in response to differentiation
cocktails for the different lineages (Boeuf and Richter, 2010;
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Noe¨l et al., 2008; Sakaguchi et al., 2005). However, these
comparisons are predicated on the notion that the primary driving
factor for MSC differentiation is soluble factors, which may not
be true.
Biophysical cues from the microenvironment and neighboring
cells may also contribute to the lineage fate and differentiation
efficiency of MSCs. For example, seeding density has been shown
to impact the efficiency of adipogenesis (Lu et al., 2009) or
chondrogenesis in vitro (Nakahara et al., 1991a; Seghatoleslami
and Tuan, 2002), and our group and others have demonstrated that
lineage commitment of human bone marrow-derived cells
(hBMCs) to osteogenesis/adipogenesis (Kilian et al., 2010;
McBeath et al., 2004) or myofibroblastogenesis/chondrogenesis
(Gao et al., 2010) is in part regulated by cell shape and/or RhoA-
mediated cytoskeletal tension. Despite the central role of cell shape
and cytoskeletal forces in regulating hBMCs, these findings have
not been extended to MSCs from other tissue sources. Thus, the
reported differences in differentiation efficiency between various
MSC types may partially originate from differences in
mechanotransduction in these other MSC types. It is even
possible that poor differentiation of varying MSC types could be
rescued by manipulating adhesive or mechanical parameters.
Similar to hBMCs, human periosteum-derived cells (hPDCs)
display MSC-like multipotency from single cell-derived clonal
populations (De Bari et al., 2006) and contribute to robust bone
and cartilage growth and repair in vivo (Colnot, 2009; De Bari et
al., 2006; Eyckmans and Luyten, 2006). hPDCs are distinct from
hBMCs in their tissue of origin, but both cell types arise from
mesoderm-derived populations during embryonic development.
Because periosteal cells, not bone marrow cells, predominantly
contribute to fracture healing in postnatal life (Colnot, 2009;
Maes et al., 2010), hPDCs may even be a more suitable cell
population for bone engineering applications (Agata et al., 2007;
Zhu et al., 2006). Thus hPDCs are a clinically relevant source of
primary mesenchymal progenitors that is currently understudied
in regard to its molecular regulation of differentiation (Mahajan,
2012), particularly as hPDC-based bone grafts are already being
used in the clinic to treat patients (Trautvetter et al., 2011).
Although in vitro differentiation assays for hPDCs were
successfully adopted from media conditions used for hBMCs, in
this paper, we report a comparison of the effects of biophysical
conditions on differentiation of these two primary human MSCs.
In particular, we examine the role of cell seeding density, cell
shape, and RhoA-mediated cytoskeletal tension on mesenchymal
stem cell differentiation in vitro to osteogenic, adipogenic, and
chondrogenic lineages.
Results
Population dynamics of hBMCs and hPDCs in culture
Cell seeding density, or the number of cells plated per square cm,
impacts cell behavior. Our previous studies showed a link
between cell seeding density and proliferation rates in multiple
cell types (Nelson and Chen, 2002), and between seeding density
and differentiation efficiency in MSCs (McBeath et al., 2004).
Thus, we first compared the proliferation rates of hBMCs and
hPDCs under different seeding densities. Independently of the
cell culture vessel used, hPDCs proliferated faster than hBMCs
and reached full confluence after 10 days (Fig. 1A) when initially
seeded at low seeding density (5000 cells/cm2). In addition, the
cell density of hPDCs obtained at confluence was consistently
higher as compared to hBMCs, which suggested that hPDCs are
smaller than hBMCs. Indeed, side-by-side comparison of
adherent hBMC and hPDC populations under phase contrast
microscopy suggested that hBMCs were more spread on tissue
culture plastic with a broader cytoplasmic body than hPDCs
(Fig. 1B, white arrows), whereas hPDCs displayed a more
spindle-shaped phenotype (Fig. 1B, black arrows).
To examine how initial seeding density impacted hBMC and
hPDC populations, we empirically chose three seeding densities,
5000 (5 k/cm2), 25000 (25 k/cm2), and 85000 (85 k/cm2). When
seeded at 5 k/cm2, both hPDCs and hBMCs attached efficiently
as mostly isolated cells with few if any cell–cell contacts. At
Fig. 1. Morphological and growth characterization of hBMCs
and hPDCs. (A) Growth curves of hBMCs (human bone marrow-
derived cells) and hPDCs (human periosteum-derived cells) over
2 weeks in culture. (B) Phase contrast images of hBMCs and
hPDCs at one day after seeding at 5 k/cm2, 25 k/cm2, and 85
k/cm2 (scale bar 5 100 mm). White arrowheads indicate flattened
morphology whereas black arrowheads indicate spindle-shaped
morphology. (C) Growth kinetics of hBMCs (2 donors/2
experiments) and hPDCs (4 donors) seeded at different densities
from passage 4. All error bars indicate standard error of the mean
(n53 hBMC donors or 4 hPDC donors).
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25 k/cm2, both cell types arranged in a nearly confluent, but not
densely packed, monolayer of cells in which cells remained well
spread against the substrate but also displayed augmented cell–cell
contact. At 85 k/cm2, both cell types appeared smaller, highly
packed, and extended processes over each other (Fig. 1B), but a
significant number of hBMCs did not attach after seeding at 85
k/cm2. Because differentiation experiments last one to two weeks,
we quantified the extent to which cell proliferation affected cell
density over time at the different seeding densities. hBMCs seeded
at 5 k/cm2 or 25 k/cm2 reached a cell density of 35 k/cm2 (62.6
k/cm2) and 41 k/cm2 (64.1 k/cm2), respectively, whereas hPDCs
at those seeding densities expanded to 55 k/cm2 (65 k/cm2) and
64 k/cm2 (64.6 k/cm2). Cell density did not change over time for
both cell types when seeded at 85 k/cm2, though fewer hBMCs
than hPDCs attached at this density (Fig. 1C).
Seeding density modulates multipotent differentiation in both
hPDCs and hBMCs
To test whether seeding density modulates differentiation, hBMCs
and hPDCs were seeded at 5 k/cm2, 25 k/cm2, and 85 k/cm2 and
subsequently treated with chondrogenic, adipogenic, or osteogenic
media. Regardless of seeding density, cells cultured exclusively in
growth medium did not undergo differentiation, as determined by
upregulation of markers for the various lineages (data not shown).
For chondrogenic differentiation, cells were plated as both
monolayer and as micromass cultures (400 k cells/20 ml droplet).
Micromass pellet cultures were included for comparison because it
is considered to be the gold standard format for chondrogenesis.
Indeed, increasing seeding density promoted expression of
chondrogenic marker genes such SOX9 (Fig. 2A), and collagen
type IIa1 (COL2A1) (Fig. 2B) for both cell types with the highest
levels of gene expression in the micromass cultures. Interestingly,
COL2A1 expression was significantly higher in hPDCs as
compared to hBMCs, suggesting that hPDCs may be more prone
to chondrogenic differentiation than hBMCs. Of note, cells seeded
in monolayer at 85 k/cm2 detached from tissue culture plastic after
three days of treatment with chondrogenic medium. This seeding
condition was therefore omitted from further analysis for
chondrogenic assays (data not shown).
Increasing seeding density also promoted adipogenic
differentiation of both cell types (Fig. 2C–F). After two weeks
of treatment, all conditions displayed lipid droplets that stained
positive for Oil Red O (Fig. 2C; insets display higher
magnification of lipid droplets within differentiated cells).
Quantification of Oil Red O positive cells demonstrated an
increased number of adipogenic cells at 85 k/cm2 as compared to
5 k/cm2 for both cell types. However, there was a tenfold higher
efficiency of adipogenic differentiation in hBMCs versus hPDCs
(Fig. 2D). Similar results were obtained when measuring gene
expression of PPARG2, a key transcription factor for adipogenic
differentiation (Fig. 2E). Transcription of lipoprotein lipase (LPL),
an enzyme involved in lipid metabolism, was upregulated by
increased seeding density in hBMCs but not in hPDCs (Fig. 2F).
Fig. 2. Chondrogenic differentiation and adipogenic
differentiation are modulated by cell seeding density in
hPDCs and hBMCs. Gene expression of SOX9 (A) and
COL2A1 (B), relative to GAPDH expression, in hBMCs
and hPDCs seeded at 5 k/cm2, 25 k/cm2, or as a micromass
(mMass, 400 k/20 ml) and stimulated for 14 days with
chondrogenic medium. (C) Oil Red O staining of hBMCs
and hPDCs seeded at indicated cell densities and treated for
two weeks with adipogenic medium (scale bar 5 100 mm).
(D) Quantification of Oil Red O (ORO) positive cells
relative to total cells as indicated by DAPI nuclear staining.
Gene expression of PPARG2 (E) and LPL (F), relative to
GAPDH expression, for hBMCs and hPDCs seeded at the
indicated cell densities and cultured for two weeks in
adipogenic medium. Relative gene expression values are
shown as 22DCT (where DCT 5 CT value for Gene of
interest 2 CT value for GAPDH). All error bars indicate
standard deviation (n53, #: p # 0.05, unpaired two-tailed
t-test).
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Unlike chondrogenesis and adipogenesis, the comparisons
between hBMCs and hPDCs with respect to osteogenic
differentiation were less clear. First, osteogenic medium
induced transient alkaline phosphatase (ALP) activity in
hBMCs by one week after stimulation, whereas two weeks of
osteogenic induction were required to induce ALP activity in
hPDCs (Fig. 3A). This difference in ALP kinetics between
hBMCs and hPDCs is in line with previous reports (Chai et al.,
2011; Eyckmans and Luyten, 2006; Jaiswal et al., 1997). Second,
hBMCs but not hPDCs displayed spontaneous ALP activity in
growth medium when seeded at high density. Third, seeding
hBMCs but not hPDCs at 25 k/cm2 resulted in more ALP
positive cells (Fig. 3B) and increased mineralization (Fig. 3A) as
compared to seeding at 5 k/cm2. These findings at the level of
protein activity were further supported by gene expression
analysis for the osteogenic markers RUNX2, ALP, and
osteocalcin (OCN). After two weeks of stimulation with
osteogenic medium, hBMCs plated very densely at 85 k/cm2
displayed higher levels of RUNX2 and OCN in comparison with
lower seeding densities, whereas ALP gene expression peaked at
one week in the intermediate seeding density 25 k/cm2 condition
(Fig. 3C). By the third week, extensive calcification of the cell-
secreted matrix prevented efficient RNA extraction from hBMCs
(data not shown). In contrast to hBMCs, seeding density did not
affect expression of the osteogenic marker genes in hPDCs
during the first two weeks of stimulation. By three weeks after
stimulation, however, hPDCs seeded at low density tended to
express higher mRNA levels of ALP and OCN (Fig. 3C). The
absence of an effect of cell density on RUNX2 and the relatively
mild effect on ALP and OCN expression in hPDCs suggest that
osteogenic differentiation in hPDCs may be less sensitive than
the hBMCs to cues affected by cell density.
Seeding density affects cell shape of hPDCs and hBMCs
The augmented differentiation response observed at higher
seeding densities could be attributed to multiple co-varying
factors that inevitably change when increasing the number of
cells in a culture vessel, such as cell-extracellular matrix
adhesion, cell–cell contact, paracrine signaling, and cell shape.
In contrast to epithelial cells that form a monolayer upon full
Fig. 3. Cell seeding density affects osteogenic
differentiation. (A) Enzymatic staining of alkaline
phosphatase (ALP) in hBMCs and hPDCs seeded at the
indicated cell densities and treated with osteogenic or
growth medium for 1 and 2 weeks or stained for
mineralization with alizarin red after 3 weeks of osteogenic
stimulation or growth medium. (B) Quantification of ALP
positive cells relative to total cells shown at the indicated
timepoints, which differ due to distinct ALP kinetics
between these two cell types. (C) Gene expression of the
bone markers, RUNX2, ALP, and osteocalcin (OCN), all
relative to the expression of GAPDH, for hBMCs and
hPDCs seeded at the indicated cell densities and cultured
for the indicated duration in osteogenic medium. By the
third week of hBMC culture, extensive calcification of the
cell-secreted matrix prevented efficient RNA extraction
despite repeated attempts (data not shown). All error bars
indicate standard deviation (n53, #: p # 0.05, unpaired
two-tailed t-test).
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confluency, primary MSCs can expand on top of each other,
giving rise to multilayered cell sheets. By consequence, the
surface area to which a cell can adhere is not exclusively
restricted by the number of seeded cells. To gain insight into how
seeding density impacts cell shape in hPDCs and hBMCs, we
tagged a fraction of the cells with cytoplasmic GFP and mixed
them with non-fluorescent cells prior to seeding at different cell
densities. The next day, the medium was replaced by growth,
osteogenic, or adipogenic medium for two more days.
Measurements of projected area of cells at 20 hours after
seeding confirmed our initial observation that hPDCs were less
spread than hBMCs when seeded at 5 k/cm2, and that cell area
was significantly reduced in conditions seeded at 25 k/cm2
(hBMCs) and 85 k/cm2 (hBMCs and hPDCs) (Fig. 4A,B).
Furthermore, spread area remained inversely correlated with
initial seeding density up to day 3. For both cell types, the
variability in cell size was consistently reduced at high seeding
densities (Fig. 4B,C), suggesting that cell shape is more
homogenous in high cell density cultures. In addition to the
effects of seeding density on cell area, treatment with adipogenic
medium also reduced cell area at higher seeding densities
(Fig. 4C), demonstrating that cell shape is in part regulated by
soluble factors.
Cell shape regulates differentiation of both hPDCs and hBMCs
Because cell shape appeared to be influenced by cell density, we
utilized fibronectin micropatterning techniques to directly assess
the impact of cell shape on MSC differentiation without the
complex effects of seeding density. Briefly, 25mm625mm
(625 mm2) or 100mm6100mm (10000 mm2) fibronectin islands
were stamped on a polydimethylsiloxane surface, followed by
seeding of hBMCs and hPDCs. We used smaller fibronectin
patterns (625 mm2) here than previously utilized for hBMCs
(1024 mm2) (Gao et al., 2010; McBeath et al., 2004) since hPDCs
are smaller than hBMCs (Fig. 4B). Cells that adhered to 625 mm2
fibronectin islands adopted a round, unspread cell shape, while
the cells on the larger fibronectin patterns were able to spread out
to a surface area of 10000 mm2 (Fig. 5A). As such cell shape is
altered without modulating seeding density.
Under these conditions, treatment of hBMCs and hPDCs with
chondrogenic medium for two weeks resulted in an increased
percentage of cells that stained positive for collagen type II when
adherent on small 625 mm2 versus large 10000 mm2 islands
(Fig. 5A). Similarly, hBMCs seeded on small patterns versus
large patterns displayed higher levels of mRNA expression for
the chondrogenic marker SOX9 (Fig. 5B). Although a similar
trend was observed in hPDCs for COL2A1, the effect was not
significant due to the high variability between experiments.
COL2A1 expression in hBMCs was only detected in small
patterned cells in one of four experiments (Fig. 5B). These
micropatterned data show that chondrogenic gene expression in
hPDCs appears to be less regulated by cell shape than that in
hBMCs, whereas chondrogenic expression at the protein level is
similarly regulated by shape in both cell types. Thus the
promotion of chondrogenic gene expression by increased cell
density in hPDCs may be more heavily influenced by density-
induced cues other than cell spreading, such as increased cell–
cell signaling. Nonetheless, the trend toward improved
Fig. 4. Seeding density modulates cell shape in both cell
types. (A) Fluorescent microscopy images of GFP-labeled
hBMCs and hPDCs mixed with unlabeled cells and seeded
at different densities. Images are taken 3 days after seeding
in presence of osteogenic (OSTEO) or adipogenic (ADIPO)
differentiation medium for the last 2 days, or growth
medium (GROWTH) for all 3 days (Green: GFP, Blue:
DAPI counterstained nuclei, scale bar 5 100 mm).
(B) Quantification of cell spread area for GFP-labeled
hPDCs and hBMCs at 20 hours after seeding (#: p # 0.05,
comparing to 5 k/cm2 condition; b: p # 0.05, comparing to
hBMCs seeded at the same density; o: outliers).
(C) Quantification of cell spread area at 3 days after
seeding (#: p# 0.05, comparing to 5 k/cm2 condition in the
same medium, a: p # 0.05, comparing to the same seeding
condition in growth medium, b: p # 0.05, comparing to
hBMCs under the same seeding/medium conditions. 30–60
cells were counted per condition. Statistical significance
calculated by ANOVA and Tukey’s post hoc test).
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chondrogenesis in small versus large patterns still suggests some
contribution of cell spreading to the observed increase in
chondrogenesis with high seeding densities.
Comparable to chondrogenesis, directly restricting cell
spreading also promoted adipogenic differentiation. The
percentage of Oil Red O positive hBMCs and hPDCs was
higher in cells constrained on small fibronectin islands as
compared to cells patterned on large islands (Fig. 5C). These data
were supported by gene expression analysis of PPARG2 and
LPL, which tended toward higher levels of expression in
unspread as compared to spread hBMCs (Fig. 5D). Although
similar trends were obtained for unspread and spread hPDCs
within single experiments, there was considerable variability
across experiments (Fig. 5D).
In contrast to the adipogenic and chondrogenic lineages, the
osteogenic marker ALP was expressed at lower levels in unspread
Fig. 5. Cell shape controls differentiation in hPDCs and hBMCs. Chondrogenic (A,B), adipogenic (C,D), and osteogenic (E,F) differentiation of hBMCs
and hPDCs patterned on 625 mm2 or 10000 mm2 fibronectin islands and cultured in the indicated medium for 2 weeks. A,C,E show representative cell images and
quantification of cells staining positive for (A) collagen type II (green: Collagen II, blue: DAPI counterstaining), (C) Oil Red O (hematoxylin counterstaining), and
(E) ALP. White dashed box in (A) outlines one 625 mm2 and one 10000 mm2 fibronectin pattern (scale bar 5 100 mm). Gene expression of markers indicative for
chondrogenesis (B, SOX9 and COL2A1), adipogenesis (D, PPARG2 and LPL), and osteogenesis (F, ALP and RUNX2), expressed relative to GAPDH. All error bars
indicate standard error of the mean (n52 hBMC donors or 4 hPDC donors; n53–6 independent experiments per lineage; $: result obtained in only one experiment).
(#: p # 0.05, Mann-Whitney U test for A–E, unpaired two-tailed t-test for F).
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versus spread cells. When spread on large fibronectin islands,
more hBMCs and hPDCs displayed ALP activity (Fig. 5E) and
increased ALP gene expression (Fig. 5F) as compared to size-
restricted cells. However, cells adherent to small patterns showed
significantly higher levels of RUNX2 mRNA transcripts
(Fig. 5F). As RUNX2 is an earlier marker of osteogenesis than
ALP (Otto et al., 1997), these findings are consistent with a
possibility that different degrees of cell spreading may be optimal
for different stages of differentiation. Interestingly, the
observation that increased cell spreading enhanced ALP
expression via micropatterning, and that increasing cell seeding
density (which decreases cell spreading) either enhanced
(hBMCs) or decreased ALP expression (hPDCs), suggests that
increased hBMC seeding density introduces an additional pro-
osteogenic cue that is independent of cell shape.
Impaired RhoA/ROCK signaling affects differentiation of hPDCs
Because changes in cell shape alter cytoskeletal tension and
RhoA/Rho Kinase (ROCK) activity (Bhadriraju et al., 2007;
McBeath et al., 2004), it has been hypothesized that RhoA/
ROCK signaling may regulate MSC differentiation. Indeed, we
have previously demonstrated in hBMCs that manipulation of
RhoA/ROCK signaling modulates osteogenic versus adipogenic
commitment when cells are treated with a mixed osteogenic/
adipogenic stimulation medium (McBeath et al., 2004). In
addition, hBMC osteogenesis is inhibited by treatment with the
ROCK inhibitor Y27632 (Wang et al., 2011). Others have shown
that RhoA/ROCK signaling also regulates chondrogenic
differentiation in adipose tissue-derived MSCs (Lu et al., 2010)
and gingiva-derived MSCs (Hsu et al., 2012). No data have yet
been reported, however, regarding a role for RhoA/ROCK
signaling in hPDCs. Here we examined whether inhibition of
RhoA/ROCK signaling, by addition of the ROCK inhibitor
Y27632, alters osteogenic, adipogenic, and chondrogenic
differentiation in hPDCs seeded at low and high density.
Y27632 treatment caused micromasses to remain adherent to
tissue culture plastic as compared with non-treated controls
indicating drug efficacy (Fig. 6A, bright field image inset).
However, Y27632 treatment did not significantly influence
chondrogenic differentiation for any conditions as measured by
alcian blue uptake, even though measurements trended toward
significance for Y27632-treated micromasses (Fig. 6A). At the
gene expression level, chondrogenesis for hPDCs seeded as
micromasses was modestly enhanced by Y27632 treatment, but
not for hPDCs seeded at low density (Fig. 6B).
For adipogenesis, Y27632 treatment increased the percentage
of Oil Red O positive cells (Fig. 6C) and upregulated gene
transcription of PPARG2 and LPL (Fig. 6D) in hPDCs seeded at
low density. The additional fraction of lipid droplet-forming
adipogenic cells induced by Y27632 at low seeding density did
not reach the level of adipogenic cells without Y27632 at high
seeding density. These trends did not reach statistical significance
for cells seeded at high density.
In contrast, ALP activity (Fig. 6E) and ALP and RUNX2 gene
expression (Fig. 6F) were significantly downregulated in the
presence of Y27632 for hPDCs seeded at low density. In hPDCs
seeded at high density, osteogenic gene expression but not ALP
activity was suppressed by Y27632. Interestingly, Y27632
treatment even in osteogenic differentiation medium resulted in
a small but detectable number of cells that produced lipid
droplets staining positive for Oil Red O (supplementary material
Fig. S1). These results in hPDCs are consistent with reports of
Y27632-induced effects on mesenchymal differentiation in
hBMCs (McBeath et al., 2004), suggesting that cytoskeletal
tension-mediated regulation of differentiation is conserved for
hPDCs. Of note, addition of Y27632 did not significantly affect
proliferation of hPDCs cultured in any of the differentiation
media as compared to untreated controls over the duration of the
differentiation experiments (data not shown), indicating that
Y27632 was not toxic to the cells.
Discussion
Cells undergo dynamic changes in cell shape during embryonic
morphogenesis in vivo (Mammoto and Ingber, 2010), but only
recently have scientists had the tools to manipulate cell shape in
vitro, for instance by micropatterning (Eyckmans et al., 2011).
With the ability to test the hypothesis in vitro that cell shape
influences stem cell fate, we and other groups have recently
demonstrated that cell shape can modulate the multipotential
lineage commitment of hBMCs (Gao et al., 2010; Kilian et al.,
2010; McBeath et al., 2004). Micropatterned hBMCs in mixed
osteogenic/adipogenic media give rise to either fate depending on
the initial spread cell area, and contractility inhibitors promote
‘‘round’’ cell fates like adipogenesis while inhibiting osteogenic
differentiation (McBeath et al., 2004). In addition, increases in
cell density impose physical constraints on cell shape, leading to
decreased projected cell area (McBeath et al., 2004; Nelson and
Chen, 2002; Xu et al., 2010). In this study, we extend these
findings to hPDCs and show that differentiation efficiency in
hBMC and hPDC populations can be guided by changing seeding
density or cell shape. In both cell types, increasing cell seeding
density or reducing cell spreading yielded better adipogenic and
chondrogenic differentiation. In addition, the effect of inhibiting
RhoA/ROCK signaling in hPDCs partially mimicked cell
density/shape dependent differentiation effects, which is
consistent with what has already been published for hBMCs
(Gao et al., 2010; McBeath et al., 2004; Wang et al., 2011).
Moreover, this study is in line with prior work suggesting that
ROCK acts downstream of the effects of cell shape on
differentiation (McBeath et al., 2004), since despite the fact
that Y27632 induces a differentiation phenotype of a less spread
cell, morphologically Y27632 either does not impact cell shape
or enhances cell spreading.
Interestingly, while our data showed consistent trends for
regulation of chondrogenic and adipogenic differentiation by cell
adhesion, shape, and mechanics in both hBMCs and hPDCs,
mechanoregulation of osteogenic differentiation was more
complex. Increasing seeding density significantly decreased
(hPDCs) or increased (hBMCs) the fraction of MSCs
expressing active ALP protein, but ALP gene expression and
protein activity were higher in MSCs on spread versus small
patterns. Because higher cell density not only decreased cell
spreading, but also would be expected to increase the level of
paracrine (diffusible) and juxtacrine (cell–cell contact) signaling
from neighboring cells, these data suggest the presence of a pro-
osteogenic signal with increasing seeding density that opposes
and masks the underlying spreading-dependent osteogenic signal.
That is, the biomechanical effect of cell spreading on promoting
osteogenic differentiation may be concealed by pro-osteogenic
cell–cell signaling effects in high density cultures but exposed by
the micropatterned cultures. Cell type-specific differences in
sensitivity to this phenomenon may explain why osteogenesis
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in hPDCs was less affected by cell density manipulations than in
hBMCs, while both cell types responded to differences in spread
cell area through micropatterning. In addition, we observed that
confining hPDCs on small fibronectin islands yielded a higher
percentage of adipogenic differentiation in comparison to hPDCs
with the same spread area in high density cultures, suggesting
that these paracrine/juxtacrine signals also suppress hPDC
adipogenesis. Paracrine signaling may also strongly influence
chondrogenic differentiation in hPDCs, since chondrogenic gene
expression was promoted by high density cultures to a greater
degree than by small, unspread patterned cultures. Indeed,
paracrine signals have been shown to impact differentiation.
For instance, changes in paracrine PDGF signaling can modulate
the cardiomyogenic potential of mouse BMCs (Pallante et al.,
2007). In another study using a microfluidic platform designed to
continuously wash away cell-secreted factors, investigators found
a requirement for paracrine signaling in mouse embryonic stem
cells committing to the neuroectodermal lineage (Blagovic et al.,
2011). Hence increased cell density may partially mediate
differentiation effects by enhancing paracrine signaling, via
both the greater numbers of cells able to secrete signaling factors
and the decreased diffusion distance between neighboring cells.
In fact, a critical mass of MSCs in osteogenic scaffolds is
required for bone formation to occur in vivo (Eyckmans et al.,
2010; Mankani et al., 2007), indicating that cell–cell signaling is
indispensible in certain differentiation assays. Our results show
Fig. 6. Inhibition of RhoA/ROCK signaling promotes adipogenesis and chondrogenesis but inhibits osteogenesis in hPDCs. Chondrogenic (A,B), adipogenic
(C,D), and osteogenic (E,F) differentiation of hPDCs seeded at 5 k/cm2 or as a micromass (mMass, 400 k/20 ml) (A,B), or at 85 k/cm2 (C–F), and cultured for 2
weeks in chondrogenic, adipogenic, or osteogenic medium containing no drug (control) or the ROCK inhibitor Y27632 at 10 or 25 mM. A,C,E display quantification
of cells staining positive for (A) alcian blue, (C) Oil Red O, and (E) ALP. (A) also shows representative alcian blue staining images, demonstrating that Y27632
treatment improved micromass adherence. Relative gene expression (22DCT with DCT5(CT value for Gene of interest2CT value for GAPDH)) of differentiation
markers indicative for chondrogenesis (B, SOX9 and COL2A1), or 22DDCT as normalized to the 5 k/cm2 control condition for adipogenesis (D, PPARG2 and LPL) and
osteogenesis (F, ALP and RUNX2). All error bars indicate standard error of the mean (#: p # 0.05, comparing to control condition for the same seeding condition;
unpaired two-tailed t-test for n54 hPDC donors; N.D.: not detected or result obtained in only one experiment).
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that effects of both shape and cell–cell signaling are important for
chondrogenesis and osteogenesis in hPDCs, suggesting that these
cues are relevant to cartilage and bone formation and repair.
These findings are consistent with literature showing that hPDCs
implanted at high cell density, but not low density, in vivo appear
to pass through an early chondrogenic phase (Nakahara et al.,
1991b).
It is clear from our data and other reports, however, that
differences in cell shape can affect differentiation independently of
cell–cell contact. The mechanisms by which cell shape regulates
MSC differentiation and other cell behaviors remain to be
elucidated. There is mounting evidence for the involvement of
focal adhesion signaling and cytoskeletal tension as key factors.
Focal adhesions serve dual functions as biophysical anchorage
points between the cytoskeleton and the extracellular matrix and as
active signaling sites. Altering adhesive conditions may influence
the availability or activity of various signaling molecules that
localize to adhesions and have been implicated in differentiation,
including FAK, Src, b-catenin, and MAPK proteins, among others
(Blagovic et al., 2011; Kuo et al., 2011; Miyamoto et al., 1995;
Schiller et al., 2011). Additionally, focal adhesion maturation is
correlated with increased RhoA-mediated cytoskeletal tension and
the formation of stress fibers (Ridley and Hall, 1992; Riveline et
al., 2001), both of which contribute to cell shape (Chen et al., 2003;
Tan et al., 2003). Inhibition of cytoskeletal tension via drugs like
the ROCK inhibitor Y27632 has been reported to regulate
mesenchymal differentiation in hBMCs and adipose-derived
MSCs (Lu et al., 2010; McBeath et al., 2004; Wang et al., 2011;
Xu et al., 2010). Similarly in our experiments, treatment of hPDCs
with Y27632 promoted adipogenic differentiation but reduced
osteogenic differentiation. Although cytoskeletal tension is
required for stabilization of adhesions, it also impacts cellular
signaling at the transcriptional level. Actomyosin-mediated
contractility regulates nucleocytoplasmic transport of mRNA
binding proteins (Lee et al., 2004; Oleynikov and Singer, 2003)
and transcription factors such as Yes-associated protein (YAP) and
transcriptional coactivator with PDZ binding motif (TAZ), both of
which are involved in osteogenic/adipogenic differentiation
(Dupont et al., 2011). Actin polymerization also drives nuclear
localization of serum response factor (SRF) and its co-factor
myocardin-related transcription factor (MRTF) (Vartiainen et al.,
2007), which can drive terminal differentiation of epidermal stem
cells (Connelly et al., 2010) and epithelial-mesenchymal transition
(Gomez et al., 2010). Thus cytoskeletal tension and
mechanochemical signaling at adhesions contribute to the role of
cell shape in regulation of stem cell differentiation.
Taken together, these studies suggest that mechanoadhesive
regulation of differentiation extends beyond hBMCs to hPDCs,
and that this process likely plays a role in many if not all MSCs.
As such, adhesive and mechanical cues will need to be optimized
for each MSC source in order to fairly compare differentiation of
different stem cells. For instance, in our experiments, the best
condition for adipogenic differentiation of hBMCs was at high
seeding density, whereas hPDC adipogenic commitment was
better on small micropatterns with minimized cell–cell signals.
Another example is that because hPDCs are smaller and spread
less than hBMCs, the seeding densities and micropattern area that
impacted differentiation were shifted. Thus, the general
mechanisms by which biophysical cues regulate behavior may
be conserved across different stem cells, but the relative
importance and optimal conditions may differ for each cell
type. Given this, comparison studies between cell types should
carefully control for and describe biophysical parameters for
accurate replication in future work, which may also reduce some
of the reported variability in MSC differentiation studies.
Materials and Methods
Cell culture and assessment of growth curves
hBMCs from two donors were purchased from Lonza (Walkersville, MD, USA)
and expanded in Dulbecco’s Modified Eagle Medium (DMEM, 1 g/L glucose;
Mediatech Inc, Manassas, VA, USA) supplemented with 10% Fetal Bovine Serum
(FBS) (Atlanta Biologicals, Lawrenceville, GA, USA). hPDCs were isolated from
four patients and expanded in growth medium (DMEM, 4.5 g/L glucose + 10%
FBS) as described previously (Eyckmans et al., 2010). In brief, periosteal biopsies
were harvested from the proximal tibia of male and female patients (mean: 26
(614) years of age), digested in collagenase (Invitrogen, Grand Island, NY, USA)
in growth medium, collected by centrifugation, and seeded in a T25 flask in growth
medium. Non-adherent cells were removed after 5 days by changing the medium.
The ethical committee for Human Medical Research (Katholieke Universiteit
Leuven) approved all procedures, and patient informed consent forms were
obtained.
To establish growth curves, hBMCs and hPDCs were seeded in 12 well plates at
5 k/cm2. At different time points, cells were stained with DAPI and imaged with a
SPOT CCD camera (Diagnostic Instruments, Sterling Heights, MI, USA) mounted
on a Nikon TE200 microscope at 1006magnification. Nuclei were counted with
Cell Profiler (Carpenter et al., 2006).
Cell shape analysis
To assess cell shape, cells infected with a lentiviral vector encoding for enhanced
Green Fluorescent Protein (eGFP) were mixed with non-infected cells and seeded
at 5 k/cm2, 25 k/cm2, or 85 k/cm2 in growth medium. The next day, the cultures
were imaged at 1006 and medium was changed to either growth medium,
osteogenic, or adipogenic medium (Lonza). Two days later, GFP-positive cells
were imaged and analyzed in ImageJ (Abramoff et al., 2004). For each condition,
30 to 60 cells were manually outlined and projected cell area was measured.
Fibronectin micropatterning
To control cell shape, 25mm625mm (625 mm2) or 100mm6100mm (10000 mm2)
adhesive islands of fibronectin were stamped on Polydimethylsiloxane (PDMS)
(Dow Corning Sylgard 184, Midland, MI, USA) substrates as described previously
(Tan et al., 2002). Briefly, glass coverslips were spin-coated with PDMS, baked to
cure the PDMS, cleaned in 70% ethanol, rinsed with PBS, and treated with UV-
ozone (UVO Cleaner, Jelight Company Inc, Irvine, CA, USA) for 5 minutes.
Fibronectin (BD Biosciences, San Jose, CA, USA) was loaded on PDMS positive-
featured stamps at 50 mg/ml for 1 hour, rinsed in sterile water, dried with a
nitrogen gun, and stamped onto the PDMS-glass substrates. Subsequently, the
stamped substrates were blocked with pluronic F127 (BASF, Mt. Olive, NJ, USA)
to prevent cell attachment outside the fibronectin islands, and rinsed with PBS
several times before cell seeding.
Differentiation assays
For differentiation assays, passage 4 to passage 7 cells were seeded in 24 or 12
well plates at 5 k/cm2, 25 k/cm2, 85 k cells/cm2, in micromasses (400 k cells in a
20 ml droplet), or on patterned fibronectin substrates; all in growth medium
(DMEM + 10% FBS (Atlanta Biologicals, Lawrenceville, GA, USA). After
24 hours, the medium was replaced with osteogenic, adipogenic, or chondrogenic
induction media (Lonza PoeticsTM: hMSC Osteogenic Differentiation BulletKitTM
(osteo basal medium, dexamethasone, ascorbate, mesenchymal cell growth
supplement, L-glutamine, penicillin, streptomycin, b-glycerophosphate), hMSC
Adipogenic Differentiation BulletKitTM (adipo basal medium, indomethacin,
isobutylmethylxanthine, recombinant human insulin, dexamethasone, GA-1000
(gentamicin, amphotericin B), mesenchymal cell growth supplement, L-
glutamine), or hMSC Chondrogenic Differentiation BulletKitTM [chondro basal
medium, dexamethasone, ascorbate, ITS+ supplement (insulin, human transferrin,
selenous acid), pyruvate, proline, GA-1000, L-glutamine) supplemented with
10 ng/ml TGFb1 (StemRD, Burlingame, CA, USA)]. Differentiation induction
media were changed every other day for up to three weeks unless otherwise
stated. To reduce cytoskeletal tension during differentiation, a Rho Kinase
(ROCK) inhibitor, Y27632 (Tocris Bioscience, R&D systems Inc, Minneapolis,
MN, USA), was added to differentiation medium at a final concentration of 10 mM
or 25 mM.
Staining
Cells were fixed with 4% paraformaldehyde (Electron Microscopy Sciences,
Hatfield, PA, USA) and stained for alkaline phosphatase with Fast Blue RR Salt/
naphthol (Sigma–Aldrich, St. Louis, MO, USA), lipid droplets with Oil Red O
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(Sigma–Aldrich) in 60% isopropanol, and nuclei with DAPI or hematoxylin.
Highly sulphated mucins, characteristic for cartilage-like matrix, were stained with
alcian blue 8GX (in 0.5 M HCl, pH 1.5) (Sigma–Aldrich) for 24 hours. After
washing, dye bound to the matrix was extracted with 6 M guanidium chloride
(Sigma–Aldrich) and absorbance was measured at 592 nm with a GENios
microplate reader (Tecan, Durham, NC, USA). Mineralization was stained by
Alizarin Red S (Acros Organics, Fair Lawn, NJ) as a 2% solution in water with pH
adjusted to 4.2 with 10% ammonium hydroxide for 15 min followed by washes.
Immunohistochemistry for collagen type II was performed with a monoclonal
mouse anti-human collagen type II antibody (1:300 dilution) (MP Biomedicals,
Solon, OH, USA) as a primary antibody and a goat anti-mouse alexa 488
conjugated (Invitrogen) as secondary antibody, as described previously (Gao et al.,
2010).
RNA extraction and quantitative PCR
RNA was extracted with the RNA micro/minikit from Qiagen (Qiagen Sciences,
Germantown, MD, USA) according to the manufacturer’s protocol.
Complementary DNA (cDNA) was obtained by reverse transcription of 1 mg of
total RNA with qScriptTM cDNA Supermix (Quanta Sciences, Gaithersburg, MD,
USA). Realtime PCR was performed in 20 ml reactions using the PerfeCTaTM
mastermix (Quanta Sciences) and a 7300 Real Time PCR System (Applied
Biosystems, Foster City, CA, USA) cycling at 95 C˚ for 3 seconds and 60 C˚ for
20 seconds for 40 cycles. The following TaqmanH primer/probe sets (Applied
Biosystems) were utilized for marker gene expression: RUNX2: Hs00231692_m1,
ALP: Hs00758162_m1; OCN: Hs01587814_g1; SOX9: Hs00165814_m1;
COL2a1: Hs00264051_m1; PPARG2: Hs00234592; LPL: Hs00173425; GAPDH:
Hs99999905_m1. Relative gene expression is shown either as (1) 22DCT with
DCT5[CT value for Gene of interest2CT value for Glyceraldehyde 3-phosphate
dehydrogenase (GAPDH)] where the Gene of Interest is a differentiation marker,
or (2) 22DDCT as normalized to the 5 k/cm2 control condition in the same media
condition, as detailed in each figure legend.
Statistical analysis
For each graph, the mean represents the average of three to six experiments.
Statistical comparisons between experimental conditions were performed utilizing
a Mann-Whitney U test or an unpaired two-tailed t-test. Cell projected areas under
different density and media conditions were compared with a one-way ANOVA
followed by Tukey post hoc test. For all tests, statistical significance was assigned
at p-value # 0.05.
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